SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India informs about disclosure

20 Feb 2026 Evaluate
In compliance with Regulation 30 of the SEBI (LODR) Regulations, Sanofi India has submitted the disclosure regarding Order issued by the Office of the Commercial Tax Officer, Tiruvallur, Tamilnadu. The details of the above notice as required under Regulation 30 of Listing Regulations are enclosed.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

3182.90 2.45 (0.08%)
05-Jun-2026 10:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.60
Dr. Reddys Lab 1271.05
Cipla 1384.75
Zydus Lifesciences 1086.70
Lupin 2268.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×